Use of hormone replacement therapy and adenocarcinomas and squamous cell carcinomas of the uterine cervix

被引:106
作者
Lacey, JV [1 ]
Brinton, LA
Barnes, WA
Gravitt, PE
Greenberg, MD
Hadjimichael, OC
McGowan, L
Mortel, R
Schwartz, PE
Kurman, RJ
Hildesheim, A
机构
[1] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA
[2] Georgetown Univ, Vincent T Lombardi Canc Res Ctr, Washington, DC USA
[3] Roche Mol Syst Inc, Alameda, CA USA
[4] Grad Hosp, Philadelphia, PA USA
[5] Yale Univ, Sch Med, New Haven, CT USA
[6] George Washington Univ, Div Gynecol Oncol, Washington, DC USA
[7] Milton S Hershey Med Ctr, Hershey, PA USA
[8] Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA
关键词
cervical carcinomas; hormone replacement therapy; human papillomavirus; HPV; cervical adenocarcinomas;
D O I
10.1006/gyno.2000.5731
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction. Exogenous hormones may influence the development of cervical adenocarcinomas. Incidence rates of adenocarcinomas and use of noncontraceptive hormones have increased since the 1970s, but few studies have investigated this potential relationship. Methods. We conducted a multicenter case-control study of 124 women with adenocarcinomas, 139 women with squamous eel carcinomas matched on age, diagnosis date, clinic, and stage of disease (in situ or invasive) to adenocarcinoma cases, and 307 healthy community controls who were also matched on age, ethnicity, and residence to adenocarcinoma cases. Participants completed in-person interviews regarding exogenous hormone use before diagnosis and other risk factors and volunteered cervical samples for human papillomavirus (HPV) testing via a PCR-based method. Odds ratios (ORs) with 95% confidence intervals (CIs) estimated relative risks. Results. Only 13 adenocarcinoma cases (10.5%), 7 squamous carcinoma cases (5%), and 20 controls (6.5%) had used noncontraceptive hormones for menopausal symptoms, irregular periods, or disease prevention; most use was short-term, former use. Ever-use was associated with adenocarcinomas (OR = 2.1, 95% CI 0.95-4.6) but not squamous carcinomas (OR = 0.85, 95% CI 0.34-2.1), No trends were seen with duration of use or ages at first use, but unopposed estrogens were positively associated with adenocarcinomas (OR = 2.7). Unopposed estrogens remained associated with adenocarcinomas (OR = 2.0) when analyses were restricted to the HPV-positive controls. Menopausal status was not associated with adenocarcinomas or squamous carcinomas and did not modify the other associations. Conclusion. Although small numbers warrant tentative conclusions, exogenous estrogens, especially unopposed estrogens, were positively associated with adenocarcinomas. Noncontraceptive hormones were negatively but weakly associated with squamous carcinomas. (C) 2000 Academic Press.
引用
收藏
页码:149 / 154
页数:6
相关论文
共 26 条
[1]   RISK OF CANCER IN WOMEN RECEIVING HORMONE REPLACEMENT THERAPY [J].
ADAMI, HO ;
PERSSON, I ;
HOOVER, R ;
SCHAIRER, C ;
BERGKVIST, L .
INTERNATIONAL JOURNAL OF CANCER, 1989, 44 (05) :833-839
[2]  
Breslow NE, 1980, STAT METHODS CANC RE, V1, DOI DOI 10.1097/00002030-199912240-00009
[3]  
Brett KM, 1997, AM J EPIDEMIOL, V145, P536
[4]   PROGESTERONE AND GLUCOCORTICOID RESPONSE ELEMENTS OCCUR IN THE LONG CONTROL REGIONS OF SEVERAL HUMAN PAPILLOMAVIRUSES INVOLVED IN ANOGENITAL NEOPLASIA [J].
CHAN, WK ;
KLOCK, G ;
BERNARD, HU .
JOURNAL OF VIROLOGY, 1989, 63 (08) :3261-3269
[5]   HUMAN PAPILLOMAVIRUS TYPE-16 COOPERATES WITH ACTIVATED RAS AND FOS ONCOGENES IN THE HORMONE-DEPENDENT TRANSFORMATION OF PRIMARY MOUSE CELLS [J].
CROOK, T ;
STOREY, A ;
ALMOND, N ;
OSBORN, K ;
CRAWFORD, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (23) :8820-8824
[6]   ESTROGEN AND PROGESTERONE-RECEPTOR SITES IN MALIGNANCIES OF THE UTERINE CERVIX, VAGINA, AND VULVA [J].
FORD, LC ;
BEREK, JS ;
LAGASSE, LD ;
HACKER, NF ;
HEINS, YL ;
DELANGE, RJ .
GYNECOLOGIC ONCOLOGY, 1983, 15 (01) :27-31
[7]   Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method [J].
Gravitt, PE ;
Peyton, CL ;
Apple, RJ ;
Wheeler, CM .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (10) :3020-3027
[8]   ADENOCARCINOMAS OF THE UTERINE CERVIX - THE EPIDEMIOLOGY OF AN INCREASING PROBLEM [J].
KJAER, SK ;
BRINTON, LA .
EPIDEMIOLOGIC REVIEWS, 1993, 15 (02) :486-498
[9]  
Lacey JV, 1999, CANCER EPIDEM BIOMAR, V8, P1079
[10]  
Lu X, 1999, INT J GYNECOL PATHOL, V18, P109